Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
LSTA
LSTA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
LSTA News
Investor Rights Law Firm Investigates Multiple Companies
3d ago
PRnewswire
Investor Rights Law Firm Investigates Multiple Companies for Potential Violations
3d ago
PRnewswire
Investor Rights Law Firm Investigates Multiple Companies
Feb 02 2026
Globenewswire
Investigations Launched into Multiple Company Acquisitions
Feb 02 2026
Globenewswire
Investor Rights Law Firm Investigates Multiple Companies
Jan 29 2026
Globenewswire
Monteverde Law Firm Investigates Multiple Acquisition Cases
Jan 29 2026
Globenewswire
Halper Sadeh LLC Investigates Potential Violations by Multiple Companies
Jan 28 2026
PRnewswire
Investigation of Investor Rights: SkyWater and Others
Jan 27 2026
Globenewswire
Monteverde Law Firm Investigates Multiple Acquisition Cases
Jan 27 2026
Globenewswire
Halper Sadeh Investigates Fairness of Lisata's $4.00 Sale to Kuva Labs
Jan 21 2026
Businesswire
Kuva Labs to Acquire Lisata Therapeutics at $4.00 per Share, Stock Soars 88%
Jan 21 2026
stocktwits
Lisata Therapeutics Acquired by Kuva Labs at $4.00 per Share
Jan 21 2026
Benzinga
Netflix, Inc. (NFLX) Reports Q4 Earnings Beat but Issues Lower Q1 Guidance, Shares Down 3%
Jan 21 2026
Benzinga
Lisata Therapeutics (LSTA) to be Acquired by Kuva Labs at $4 per Share, 85% Premium
Jan 21 2026
NASDAQ.COM
Lisata Therapeutics (LSTA) to be Acquired by Kuva Labs at $4.00 per Share, 180% Premium
Jan 21 2026
seekingalpha
Lisata Therapeutics (LSTA) to be Acquired by Kuva Labs for $4 per Share
Jan 21 2026
NASDAQ.COM
Show More News
